We are proud to announce that Convex Clinical Research Site is officially expanding its operations with the launch of a dedicated oncology division for conducting Phase I through Phase III oncology clinical trials. Our team has now been strengthened by the addition of six highly qualified oncologists, alongside specialized oncology nurses and clinical research coordinators, marking the official commencement of our oncology clinical research activities.
While now formally conducting oncology clinical trials at Convex Clinical Research Site, our investigators and research professionals bring many years of extensive experience in clinical research and oncology studies, reflecting a long-standing commitment to advancing innovative treatments and patient care. The research team at Convex Clinical Research Site is engaged across a broad spectrum of oncology indications, including:
- Breast Cancer
- Lung Cancer (Small Cell and Non-Small Cell Lung Cancer)
- Colorectal Cancer (Colon and Rectal Cancer)
- Prostate Cancer
- Ovarian Cancer
- Uterine and Cervical Cancer
- Endometrial Cancer
- Kidney Cancer (Renal Cancer)
- Bladder Cancer
- Pancreatic Cancer
- Liver Cancer
- Gastric (Stomach) Cancer
- Esophageal Cancer
- Head and Neck Cancers
- Thyroid Cancer
- Melanoma and Other Skin Cancers
- Sarcomas (Soft Tissue and Bone Sarcomas)
- Brain Tumors and Central Nervous System (CNS) Tumors
- Hematologic Malignancies, including: Leukemias, Lymphomas, Multiple Myeloma, Myeloproliferative and Myelodysplastic Disorders
- Rare and Solid Tumors
- Molecularly and Genetically Targeted Tumors, including Precision Oncology Approaches.
Our mission is to provide patients with early access to innovative therapies, advanced clinical protocols, and highly specialized medical care, in full alignment with international standards and best practices in clinical research.
